RESUMO
The clinical effect of the formulation of theophylline of sustained action was evaluated (Aristegui 300 mg, capsules) to the dose of 9 weight/day mg/kg (every 12 hours) in the consultation of bronchial asthma of Hospital Docente Provincial Clínico Quirúrgico de Santa Clara, in the understood period of February to September of 1997. The time of treatment was of one month and they were carried out five consultations. The sample was constituted by 30 asthmatic, moderate or severe patients. The variables were analyzed: attendance to guard's body, salbutamol use in spray and they were carried out objective mensurations from the lung function to all the patients in the different consultations. With the use of the formulation they diminished the flow expiratory pick significantly, the expiratory volume forced in one second and the flow half expiratory maximum and low incidence of adverse effects existed.
Assuntos
Asma/tratamento farmacológico , Broncodilatadores/uso terapêutico , Teofilina/uso terapêutico , Adolescente , Adulto , Preparações de Ação Retardada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Índice de Gravidade de DoençaRESUMO
La Poliarteritis nudosa (PAN) es una vasculitis necrotizante sistémica de pequeñas y medianas arterias musculares carente de signos y síntomas patógnomonicos, aunque con posibilidad potencial de afectación de todos los organos parenquimatosos. (AU)
Assuntos
Poliarterite Nodosa , HemorragiaRESUMO
El trabajo tiene como objetivo fundamental revisar algunos aspectos farmacológicos útiles para el manejo de los medicamentos antiasmático, de uso común en nuestro medio, así como algunas drogas de aparición reciente y que poseen buena aceptación internacional y que dado nuestro desarrollo en la esfera de la salud pudieran formar parte, en un futuro cercano del arsenal terapéutico en el Asma Bronquial. (AU)